SEARCH

SEARCH BY CITATION

References

  • 1
    Black N, Barker M, Payne M. Cross sectional survey of multicentre clinical databases in the United Kingdom. BMJ 2004; 328: 147881.
  • 2
    Royal College of Paediatrics & Child Health. Safer and Better Medicines for Children — Developing the Clinical and Research Base of Paediatric Pharmacology in the United Kingdom. London: RCPCH Publications Limited 2004.
  • 3
    Standing Medical Advisory Committee Advice. Licensing and Prescribing of Drugs in Children (SMAC Advice 5/2001). http://www.advisorybodies.doh.gov.uk/smacdrugschildren.htm (accessed 10062004).
  • 4
    Commission Consultation on a Draft Proposal for a European Parliament and Council Regulation (EC) on Medicinal Products for Paediatric Use. Brussels: European Commission 2004.
  • 5
    Prescription Pricing Authority. http://www.ppa.nhs.uk/index_noflash.htm (accessed 10062004).
  • 6
    Prescription Statistics Publications — Prescriptions Dispensed in the Community in England. http://www.publications.doh.gov.uk/prescriptionstatistics/index.htm (accessed 10062004).
  • 7
    Mann RD. Prescription-Event Monitoring — recent progress and future horizons. Br J Clin Pharmacol 1998; 46: 195201.
  • 8
    Wilton LV, Pearce G, Mann RD. The use of newly marketed drugs in children and adolescents prescribed in general practice. Pharmacoepidemiol Drug Saf 1999; 8 (S1): S3745.
  • 9
    General Practice Research Database. http://www.gprd.com (accessed 10062004).
  • 10
    Murray ML, De Vries CS, Wong ICK. A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Arch Dis Child 2004; 89: 1098102.
  • 11
    Kaye JA, Del Mar Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 2001; 322: 4603.
  • 12
    Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, Smith PG, Hall AJ. MMR vaccination and pervasive developmental disorders: a case–control study. Lancet 2004; 364 (9438): 9639.
  • 13
    Wong ICK, Novak-Camilleri D, Stephens P. Rise in psychotropic drug prescribing in children in the UK — an urgent public health issue. Drug Saf 2003; 26: 11178.
  • 14
    Wong ICK, Murray ML, Novak-Camilleri D, Stephens P. Increased prescribing trends of paediatric psychotropic medications. Arch Dis Child 2004; 89: 11312.
  • 15
    Medicines and Healthcare Products Agency. http://medicines.mhra.gov.uk/ (accessed 10062004).
  • 16
    Clarkson A, Choonara I. Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Child 2002; 87: 4626.
  • 17
    Independent Steering Committee. Report of an Independent Review of Access to the Yellow Card Scheme. London: The Stationery Office 2004.
  • 18
    MEMO. The Medicines Monitoring Unit. http://www.dundee.ac.uk/memo (accessed 10062004).
  • 19
    Ekins-Daukes S, Simpson CR, Helms PJ, Taylor MW, McLay JS. Burden of corticosteroids in children with asthma in primary care: retrospective observational study. BMJ 2002; 324: 1374.
  • 20
    BSPAR Biologics & New Drugs Registry. http://www.bspar.org.uk/pages/home.asp (accessed 29042005).
  • 21
    PICAnet: Paediatric Intensive Care Audit Network. http://www.picanet.org.uk/ (accessed 29042004).
  • 22
    Mehta G, Sims EJ, Culross F, McCormick JD, Mehta A. Potential benefits of the UK Cystic Fibrosis Database. J R Soc Med 2004; 97 (Suppl 44): 6071.
  • 23
    PainDB. http://www.paindb.org/ (accessed 29042005).